 |
text only |
|
|||||||||||||||||||||||||||||
Professional Profile
Research Interests: -Development of screening tests for ovarian and endometrial cancer. Honors and Academic Achievements: -Council on Resident Education in Obstetrics and Gynecology (CREOG)National Faculty Award for Excellence in Resident Education (2010) -Gynecologic Cancer Foundation (GCF) Ovarian Cancer Research Grant-Sherri’s From a Whisper to a Roar/Women’s Motorcycle Foundation Ovarian Cancer Research Award (2010) -Alabama Launchpad Business Plan Competition Second Prize Winner- Swift Biotechnology Gynecologic Cancer Screening Tests (2010) -USA Medical Student Honors Convocation- Recognition for Most Meaningful Input into Medical Education to the Class of 2010 (2010) -National Faculty Award for Excellence in Resident Education (2008) -Gynecologic Oncology Group Young Investigator Award (2007) -American College of Surgeons, William Maddox Cancer Research Award (2005) -Recipient, NIH T32 Ruth L. Kirschstein National Research Service Award (2004) Education: -M.D., University of Alabama at Birmingham. (2000) -B.S., University of Mississippi, Oxford, MS. (1994) Professional Appointments: -Member, USA Mitchell Cancer Institute, 2007 – present Service: -Reviewer, Department of Defense, Ovarian Cancer Research Program Scientist, 2009 -Society of Gynecologic Oncologists, Executive Council Representative, 2009 -Reviewer for peer reviewed journals: Gynecologic Oncology and International Journal of Gynecologic Cancer, 2008-present -Society of Gynecologic Oncologists Marketing and Communications, 2009-present Scientific Focus: Dr. Rod Rocconi’s laboratory focuses on understanding the molecular mechanisms involved in ovarian cancer progression in order to develop targeted therapies and improve treatment for patients with ovarian cancer. His work involves close collaboration with Dr. Lewis Pannell’s lab as well as Dr. Lalita Shevde-Samant’s team. Selected Publications: 1. RP Rocconi, TM Numnum, ZB Zhu, B Lu, M Wang, M Stoff-Khalili, AA Rivera, RD Alvarez, DT Curiel, S Makhija. Icodextrin Enhances Survival in an Intraperitoneal Ovarian Cancer Murine Model Utilizing Gene Therapy. Gynecologic Oncology 2006; 103: 985-989. 2. RP Rocconi, ZB Zhu, B Lu, M Stoff-Khalili, AA Rivera, B Lu, M Wang, RD Alvarez, DT Curiel, SK Makhija. Treatment of ovarian cancer with a novel dual targeted conditionally replicative adenovirus (CRAd). Gynecologic Oncology 2007; 105: 113-121. 3. RP Rocconi, KS Matthews, MK Kemper, KE Hoskins, W Wang, MN Barnes Chemotherapy Related Myelosuppression as a Marker of Survival in Epithelial Ovarian Cancer Patients During Primary Therapy. Gynecologic Oncology 2008; 108: 336-341. 4. KS Matthews, JM Estes, MG Conner, U Manne, CK Shanmugam, JM Whitworth, WK Huh, RD Alvarez, JM Straughn, MN Barnes, RP Rocconi. Lynch Syndrome in women less than 50 years of age with endometrial cancer. Obstetrics & Gynecology 2008; 111 (5): 1161-6. 5. KS Matthews, RP Rocconi, ML Kemper, KE Hoskins, W Wang, JM Straughn The Effect of Obesity on Survival in Patients with Ovarian Cancer. Gynecologic Oncology (In Press) |
||||
Rodney P. Rocconi, M.D.University of South Alabama - Mobile Alabama 36688-0002 Appointments: Medical, Surgical and Gynecologic Oncology: (251) 665-8000 Radiation Oncology: (251) 445-9615 Administration: (251) 460-6993 For questions or comments Contact Us Date last changed: July 5, 2011 5:59 PM http://www.southalabama.edu/mci/rocconi2.html |
 |